Godavari Drugs Ltd.

GODAVARI · NSE

Healthcare · —

EOD price available after 4:30 PM IST
on the next trading day

Valuation

Blended fair value using DCF and peer comparison methods.

See if Godavari Drugs Ltd. is undervalued

Unlock intrinsic value for 4,800+ Indian stocks — free.

The intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.

Peer comparison

How this company stacks up against sector peers on valuation and quality metrics.

Healthcare · 8 peers · sector medians shown

Better than medianWorse than median

Company	Mkt Cap	P/E	P/B	EV/EBITDA	ROE	Net Margin	Rev CAGR 3y
Godavari Drugs Ltd. GODAVARI · you	₹106 Cr	25.6×	2.5×	—	10.0%	0.0%	—
Sector median	—	35.4×	2.6×	13.4×	5.3%	0.1%	7.8%
Sigachi Industries Limited SIGACHI	₹1,041 Cr	40.0×	2.3×	—	5.8%	0.1%	—
Health X Platform Limited HEALTHX	₹954 Cr	796.5×	1.5×	—	0.2%	0.1%	8.3%
Bharat Parenterals Limited BPLPHARMA	₹930 Cr	96.0×	2.9×	—	3.0%	0.1%	—
Wanbury Limited WANBURY	₹915 Cr	16.4×	23.6×	—	144.2%	0.0%	—
Kopran Limited KOPRAN	₹893 Cr	34.0×	1.6×	13.4×	4.8%	3.8%	7.3%
Anlon Healthcare Limited AHCL	₹846 Cr	23.3×	3.3×	18.6×	12.6%	16.9%	15.1%
Amanta Healthcare Limited AMANTA	₹696 Cr	35.4×	2.7×	13.4×	6.8%	5.2%	3.5%
ZIM Laboratories Limited ZIMLAB	₹588 Cr	154.4×	2.5×	—	1.6%	-0.0%	—

Peer comparison verdict

Godavari looks attractively valued — trading at a discount to sector peers on P/E (25.6× vs sector median 35.4×) while delivering above-average returns on equity (10.0% vs 5.3%).

Business quality

Valuation

P/E ratio

25.6×

P/B ratio

—

EV/EBITDA

—

Price/Sales

—

Returns

ROE

10.0%

ROCE

—

ROA

—

Growth

Revenue CAGR (3yr)

—

EPS CAGR (3yr)

—

Efficiency

Asset turnover

—

FCF yield

—

Dividend yield

—

Liquidity & Solvency

Debt / Equity

—

Debt / EBITDA

—

Interest coverage

—

Current ratio

—

Quick ratio

—

Financial health

Piotroski F-Score, Altman Z-Score, and key solvency ratios.

Financial health data is not yet available for this company.

Full financial data

Charts and annual statements for income, balance sheet and cash flow.

Income trend

Revenue, profit and margin trends over time.

Income statement data is unavailable for this company.

Cash flow

Where cash comes from and where it goes.

Cash flow data is not yet available for this company.

Balance sheet

Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.

Balance sheet data is not yet available for this company.

Numbers are illustrative — order-of-magnitude correct. For precise figures, refer to the company's annual report on BSE/NSE.

Shareholding pattern

Who owns this company and how that has changed.

Shareholding data is not yet available for this company.